Fidelity Investments’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Fidelity Investments’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-115	Closed	-$6.02K	–	5696
2026 Q1	$6.02K	Buy	+115	New	+$5.85K	﹤0.01%	4880
2022 Q3	–	Sell	-1	Closed	–	–	5332
2022 Q2	$0	Buy	+1	New	+$29	﹤0.01%	5417
2022 Q1	–	Sell	-14	Closed	-$1K	–	5414
2021 Q4	$1K	Sell	14 -203	-94%	-$9.05K	﹤0.01%	4203
2021 Q3	$10K	Buy	217 +91	+72%	+$4.18K	﹤0.01%	3622
2021 Q2	$6K	Buy	126 +100	+385%	+$4.79K	﹤0.01%	3695
2021 Q1	$1K	Buy	26 +2	+8%	+$111	﹤0.01%	3876
2020 Q4	$1K	Buy	+24	New	+$1.14K	﹤0.01%	3732
2020 Q3	–	Sell	-1	Closed	–	–	3954
2020 Q2	$0	Buy	+1	New	+$39	﹤0.01%	4100
2019 Q1	–	Sell	-3	Closed	–	–	4134
2018 Q4	$0	Buy	+3	New	+$99	﹤0.01%	4072

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Fidelity Investments's SBIO Position: Q2 2026 in Review

Fidelity Investments sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 115 shares — an estimated $6.02K sold.

Fidelity Investments first reported a position in SBIO in Q4 2018 and held it in 9 quarters. The position peaked at $10K in Q3 2021. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

Fidelity Investments reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
Fidelity Investments sold 115 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $6.02K.
Fidelity Investments first reported a position in ALPS Medical Breakthroughs ETF in Q4 2018 and held it in 9 quarters.
Fidelity Investments's ALPS Medical Breakthroughs ETF position peaked at $10K in Q3 2021.
65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.